Counterregulation of Th2 immunity by interleukin 12 reduces host defenses against Strongyloides venezuelensis infection

Microbes and Infection

Volumn 11, Issue 5, 2009, Pages 571-578

  Machado, Eleuza R ^a   Carlos, Daniela ^a   Lourenço, Elaine V ^a   Sorgi, Carlos A ^a   Silva, Érika V ^a   Ramos, Simone G ^a   Ueta, Marlene T ^b   Aronoff, David M ^c   Faccioli, Lúcia H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Antibodies; Cytokines; Eosinophils; IL 12 mice; S. venezuelensis

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL COUNT; FEMALE; FEMALE FERTILITY; HOST PARASITE INTERACTION; HOST RESISTANCE; LUNG LAVAGE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PARASITE SURVIVAL; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STRONGYLOIDES VENEZUELENSIS; STRONGYLOIDIASIS; TH2 CELL;

ANIMALS; ANTIBODIES, HELMINTH; BLOOD CELLS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; EOSINOPHILS; FECES; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARASITE EGG COUNT; STRONGYLOIDES; STRONGYLOIDIASIS; TH2 CELLS;

MUS; STRONGYLOIDES VENEZUELENSIS;

EID: 67349198552     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.03.005     Document Type: Article

References (30)

1. Grove D.I. Human strongyloidiasis. Adv. Parasitol. 38 (1996) 251-309
2. Guyomard J.L., Chevrier S., Bertholom J.L., Guigen C., and Charlin J.F. Finding of Strongyloides stercoralis infection, 25 years after leaving the endemic area, upon corticotherapy for ocular trauma. J. Fr. Ophtalmol. 30 (2007) e4
3. Giavina-Bianchi P., Silva F.D.S., Toledo-Barros M., Birolini D., Kalil J., and Rizzo L.V. A rare intestinal manifestation in a patient with common variable immunodeficiency and strongyloidiasis. Int. Arch. Allergy Immunol. 140 (2006) 199-204
4. Vadlamudi R.S., Chi D.S., and Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin. Mol. Allergy 4 (2006) 8
5. Einsiedel L., and Spelman D. Strongyloides stercoralis: risks posed to immigrant patients in an Australian tertiary referral centre. Intern. Med. J. 36 (2006) 632-637
6. Thompson F.J., Barker G.L., Hughes L., Wilkes C.P., Coghill J., and Viney M.E. A microarray analysis of gene expression in the free-living stages of the parasitic nematode Strongyloides ratti. BMC Genomics 7 (2006) 157
7. Machado E.R., Ueta M.T., Lourenço E.V., Anibal F.F., Sorgi C.A., Soares E.G., Roque-Barreira M.C., Medeiros A.I., and Faccioli L.H. Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. J. Immunol. 175 (2005) 3892-3899
8. Galioto A.M., Hess J.A., Nolan T.J., Schad G.A., Lee J.J., and Abraham D. Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval Strongyloides stercoralis in mice. Infect. Immun. 74 (2006) 5730-5738
9. Mir A., Benahmed D., Igual R., Borras R., O'Connor J.E., Moreno M.J., and Rull S. Eosinophil-selective mediators in human strongyloidiasis. Parasite Immunol. 28 (2006) 397-400
10. Sasaki Y., Yoshimoto T., Maruyama H., Tegoshi T., Ohta N., Arizono N., and Nakanishi K. IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. J. Exp. Med. 202 (2005) 607-616
11. Negrão-Correa D., Pinho V., Souza D.G., Pereira A.T., Fernandes A., Scheuermann K., Souza A.L., and Teixeira M.M. Expression of IL-4 receptor on non-bone marrow-derived cells is necessary for the timely elimination of Strongyloides venezuelensis in mice, but not for intestinal IL-4 production. Int. J. Parasitol. 36 (2006) 1185-1195
12. Satoh M., Toma H., Kiyuna S., Shiroma Y., Kokaze A., and Sato Y. Association of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasis. Am. J. Trop. Med. Hyg. 71 (2004) 107-111
13. Zaiss D.M., Yang L., Shah P.R., Kobie J.J., Urban J.F., and Mosmann T.R. Amphiregulin, a Th2 cytokine enhancing resistance to nematodes. Science 314 (2006) 1746
14. Langrish C.L., McKenzie B.S., Wilson N.J., Malefyt R.W., Kastelein R.A., and Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202 (2004) 96-105
15. Naume B., Gately M.K., Desai B.B., Sundan A., and Espevik T. Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferation. Cytokine 5 (1993) 38-46
16. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., and Romagnani S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177 (1993) 1199-1204
17. Aste-Amezaga M., D'Andrea A., Kubin M., and Trinchieri G. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell. Immunol. 156 (1994) 480-492
18. Finkelman F.D., Shea-Donohue T., Goldhill J., Sullivan C.A., Morris S.C., Madden K.B., Gause W.C., and Urban J.F. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu. Rev. Immunol. 15 (1997) 505-533
19. Schmitt E., Hoehn P., Germann T., and Rude E. Differential effects of interleukin-12 on the development of naive mouse CD4 + T cells. Eur. J. Immunol. 24 (1994) 343-347
20. + T lymphocytes. J. Immunol. 155 (1995) 111-117
21. Finkelman F.D., Madden K.B., Cheever A.W., Katona I.M., Morris S.C., Gately M.K., Hubbard B.R., Gause W.C., and Urban Jr. J.F. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179 (1994) 1563-1572
22. Rotman H.L., Schnyder-Candrian S., Scott P., Nolan T.J., Schad G.A., and Abraham D. IL-12 eliminates the Th2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunol. 19 (1997) 29-39
23. Brumpt E. Précis de Parasitologie (1934), Masson et Cie, Paris pp. 1042-1045
24. Machado E.R., Ueta M.T., Gonçalves-Pires M.R., de Oliveira J.B., Faccioli L.H., and Costa-Cruz J.M. Diagnosis of human strongyloidiasis using particulate antigen of two strains of Strongyloides venezuelensis in indirect immunofluorescence antibody test. Exp. Parasitol. 99 (2001) 52-55
25. Machado E.R., Ueta M.T., Lourenço E.V., Anibal F.F., Roque-Barreira M.C., and Faccioli L.H. Comparison of immune responses in mice infected with different strains of Strongyloides venezuelensis. Parasite Immunol. 29 (2007) 549-557
26. Machado E.R., Ueta M.T., Gonçalves-Pires M.R.F., Oliveira J.B.A., Faccioli L.H., and Costa-Cruz J.M. Strongyloides venezuelensis alkaline extract for the diagnosis of human strongyloidiasis by enzyme-linked immunosorbent assay. Mem. Inst. Oswaldo Cruz. 98 (2003) 849-851
27. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., and Takatsu K. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167 (1988) 1737-1742
28. Kimura K., Song C.H., Rastogi A., Dranoff G., Galli S.J., and Lantz C.S. Interleukin-3 and c-Kit/stem cell factor are required for normal eosinophil responses in mice infected with Strongyloides venezuelensis. Lab. Invest. 86 (2006) 987-996
29. Korenaga M., Hitoshi Y., Yamaguchi N., Sato Y., Takatsu K., and Tada I. The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice. Immunology 72 (1991) 502-507
30. Myrtek D., Knoll M., Matthiesen T., Krause S., Lohrmann J., Schillinger D., Idzko M., Virchow J.C., Friedrich K., and Luttmann W. Expression of interleukin-13 receptor alpha 1-subunit on peripheral blood eosinophils is regulated by cytokines. Immunology 112 (2004) 597-604